HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab.

AuthorsNali Yang, Lele Chen, Junyi Shao, Fan Jiang, Jingjing Liu, Zhiming Li
JournalThe British journal of dermatology (Br J Dermatol) Vol. 187 Issue 5 Pg. 828-830 (11 2022) ISSN: 1365-2133 [Electronic] England
PMID35822461 (Publication Type: Letter)
Chemical References
  • dupilumab
  • Janus Kinase Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal
Topics
  • Humans
  • Dermatitis, Atopic (drug therapy)
  • Janus Kinase Inhibitors (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal
  • Treatment Outcome
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: